[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pediatric-tumor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pediatric-tumor":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100484751","use-of-virtual-reality-in-pain-management-in-pediatric-oncology-100484751",false,"NCT05592132","Use of Virtual Reality in Pain Management in Pediatric Oncology","Use of Virtual Reality in Pain Management During Invasive Gestures in Pediatric Oncology: Randomized Controlled Trial","DOREVI","Inclusion Criteria:\n\n* patient who tolerates the virtual reality headset\n* patient followed in pediatric oncology\n* patient with a diagnosis of benign tumor or cancer\n* patient who needs to have painful medical procedure during their treatment\n* patient whose parents have signed the informed consent\n* patient affiliated with social security or equivalent\n\nExclusion Criteria:\n\n* patient with visual or hearing impairement\n* patient with epilepsy or other neurological disease\n* patient with psychiatric disease","ALL","6 Years","18 Years",{"count":21,"type":22},74,"ESTIMATED","INTERVENTIONAL",[25],"NA","DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.",[28],"Pediatric Tumor","RECRUITING","2026-03-11",{"date":32,"type":33},"2026-03-13","ACTUAL",{"date":35,"type":33},"2023-01-17",{"date":37,"type":22},"2026-05",{"name":39,"class":40},"Centre Hospitalier Universitaire de la Réunion","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100617177","pediatric-midline-post-fossa-tumors-prognostic-factors-and-outcomes-100617177","NCT07315230","Pediatric Midline Post Fossa Tumors Prognostic Factors and Outcomes","Inclusion Criteria:\n\n* patients less than 18 years old\n* patient with midline posterior fossa tumors\n* patient is fit for surgery\n\nExclusion Criteria:\n\n* patinent older than 18 years old\n* patients with non-midline posterior fossa or other brain tumors.\n* patient is unfit for surgery .\n* Incomplete Data: Missing essential study data.\n* Secondary Malignancy: Metastatic disease.","0 Years","17 Years",{"count":51,"type":22},30,"OBSERVATIONAL","This study will follow children younger than 18 years with midline posterior fossa brain tumors who undergo standard surgical resection at Assiut University Hospital. The aim is to evaluate functional outcome using the modified Rankin Scale and to explore how tumor type, extent of resection, and perioperative factors are associated with postoperative morbidity and survival. Results may help improve risk stratification and guide individualized treatment strategies for pediatric patients with these tumors.",[28,55],"Midline Posterior Fossa Tumors",[57,55,58],"Pediatric","Prognostic factors","NOT_YET_RECRUITING","2025-12-18",{"date":62,"type":33},"2026-01-02",{"date":64,"type":22},"2026-01",{"date":66,"type":22},"2027-02",{"name":68,"class":40},"Assiut University"]